Raisio - Company Announcement

Benemilk Ltd has ended the assessment of funding options

Raisio plc, Stock Exchange Release 2 June 2016

BENEMILK LTD HAS ENDED THE ASSESSMENT OF FUNDING OPTIONS

On 3 November 2015, Raisio announced that its subsidiary Benemilk Ltd was
examining conditions and opportunities to obtain new financing for, on the one
hand, launching of the ingredient business and, on the other, developing its
licensing business. 

The assessment included both debt and equity financing options as well as the
new funding for Benemilk Ltd’s US subsidiary. Based on the completed
assessment, Benemilk Ltd’s Board of Directors has concluded that, at this stage
of business operations, it is not justified to implement the equity financing
scheme as the company valuation indicated by potentially interested investors
is not satisfactory for current owners. Therefore, the Board has decided to end
the process launched in November 2015. 

Benemilk Ltd’s Board of Directors and current owners are reviewing the new
situation as well as the company’s position and opportunities, and will inform
of its decisions once they have been made. 

The management company of Intellectual Development Management Fund I, LLC,
owner of 25% of Benemilk Ltd since its establishment, separated from
Intellectual Ventures entity in May 2016 to become an independent company. This
change has had no impact on the composition or work of Benemilk Ltd’s Board of
Directors. 

Benemilk has two business areas. The ingredient business is based on the sale
and marketing of palm oil-based raw material under the Primafat trade mark and
on the developed IPR. The licensing business includes the development,
commercialisation and licensing of IPR based on the Benemilk innovation. 

RAISIO PLC

Heidi Hirvonen
Communications and IR Manager
Tel. +358 50 567 3060



Further information:
Matti Rihko, CEO, tel. +358 400 830 727



Raisio plc

Raisio plc is an international specialist in plant-based nutrition. Raisio’s
operations are divided into two divisions: Brands and Raisioagro. The Group’s
key market areas are Finland, Great Britain, the Czech Republic, Russia and
Poland. Markets for cholesterol lowering Benecol products are global. Raisio
plc’s shares are listed on Nasdaq Helsinki Ltd. In 2015, the Group's net sales
totalled EUR 521 million and EBIT was EUR 51.7 million excluding one-off items.
The Group employs some 1,800 people. Raisio’s best-known brands are Benecol,
Benemilk, Elovena Honey Monster, Fox’s and Poppets. Benemilk feeds for milk
production and Benecol for cholesterol lowering are Raisio’s top innovations.
For more information on Raisio go to www.raisio.com/en 





Distribution
Nasdaq
Key media
www.raisio.com